Alchemab Therapeutics is developing natural protective antibodies designed to keep people free of hard-to-treat diseases.  The company is building their transformative engine to identify drug targets and develop a pipeline of antibody therapeutics for hard-to-treat cancers, neurodegenerative conditions, and infectious diseases. Alchemab Therapeutics was established in 2019 by Uri Laserson and Jane Osbourn in London, England.

England, UK

London, UK

Mile End, London, UK

Kingston Vale, London SW15, UK

Alchemab Therapeutics

Camford Capital Management LLC

Camford Capital

Discover opportunities across our network

Tell us about your professional DNA to get discovered by any company in our network with opportunities relevant to your career goals.

Leverage our network to build your career.

#### Welcome!

Thank you for joining Camford Network!

To help us best support you in your search, please take a few minutes to tell us about what you are looking for in your next role. We’ll use this information to connect you to relevant opportunities in the Camford network as they come up.

You can always update this information later.

Welcome to the Camford talent network

As our companies grow, they look to us to help them find the best talent.

Signal that you'd be interested in working with a Camford company to help us put the right opportunities at great companies on your radar. The choice to pursue a new career move is then up to you.

Jobs